BIOACTIVE PROTEIN AND PEPTIDES MARKET ANALYSIS

Bioactive Protein and Peptides Market, By Source (Animal(Dairy sub-segments(Whey, Casein, Milk Protein Concentrate), Egg & Meat, Gelatin, Fish & Insects, Seafood ), Plant Source (Cereals (Wheat, Corn & Others), Legumes (Soybean, Pea)(Soy protein Concentrates, Soy Protein Isolates, Textured Soy Protein)), Pseudo cereals, Brasssicaceae species, Others (Sunflower)), By Application (Functional Food, Functional Beverages, Dietary Supplements, Animal Nutrition, Personal Care, Others (Printing & Painting)), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Jan 2020
Code : CMI3402
Pages :120
Formats :
Excel and PDF
Industry : Food and Beverages

Bioactive Protein And Peptides MarketSize and Trends

The global bioactive proteins and peptides market is projected to reach US$ 88.3 billion by the end of 2027, in terms of revenue, growing at CAGR of 8.2% during the forecast period (2019 to 2027).

Regionally, North America dominated the global bioactive proteins and peptides market in 2018, reporting 35.9% market share in terms of revenue, followed by Asia- Pacific and Europe, respectively.

Market Trends

Plant-based bioactive peptide and proteins are gaining traction in the market due to the presence of low cholesterol and saturated fat content of the plant ingredient. This factor is exepcted to propel the market growth of bioactive peptides and proteins. For instance, in November 2018, BASF introduced PeptAIde, a sports nutrition ingredient containing a unique set of plant-based peptides identified using artificial intelligence (AI), for regulating inflammation. Therefore, high demand for plant-based bioactive peptides and proteins is propelling the market growth.

Increasing adoption of growth strategies such as partnerships by major players in order to expand their presence in the market and fulfill the rising demand for the peptide-based dietary supplement is accelerating the market growth. For instance, in January 2019, Nuritas and Pharmavite enter into partnership on bioactive peptides in supplements. The partnership plans to leverage Nuritas’ technology platform, which combines AI and DNA analysis to forecast, unlock and validate bioactive peptide ingredients.